§ Same category · GLP-1 / metabolic peptides
Orforglipron vs Survodutide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Orforglipron
0
vendors tracked
Survodutide
0
vendors tracked
Orforglipron
Oral small-molecule GLP-1 agonist
No current listings at 0.024mg.
Survodutide
Glucagon/GLP-1 dual agonist
No current listings at 10mg.
About Orforglipron
An oral non-peptide GLP-1 receptor agonist in Phase 3 for obesity and type-2 diabetes. Typically sold as capsules in research-compound form.
About Survodutide
A dual glucagon/GLP-1 receptor agonist in clinical trials for obesity and MASH. Research-compound version sold as the free acid.